Plunkett Research Online: Aceragen Inc

ACERAGEN INC (Private) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Aceragen, Inc. is a rare disease biopharmaceutical company committed to transforming the care of people living with rare, orphan diseases that, for the most part, have no available treatments. The company’s pipeline consists of ACG-801, which is an investigational enzyme replacement therapy for the .....


ACERAGEN INC

Ticker: Private
Exchange:
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 484-348-1600
Fax:
Address: 15 TW Alexander Dr.
Durham, NC 27709 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

John TaylorCEO
John KirbyCFO
See More
Aceragen, Inc. is a rare disease biopharmaceutical company committed to transforming the care of people living with rare, orphan diseases that, for the most part, have no available treatments. The company’s pipeline consists of ACG-801, which is an investigational enzyme replacement therapy for the .....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture